373 related articles for article (PubMed ID: 22458807)
1. Regulated interaction of protein phosphatase 1 and protein phosphatase 2A with phospholipase C-related but catalytically inactive protein.
Sugiyama G; Takeuchi H; Nagano K; Gao J; Ohyama Y; Mori Y; Hirata M
Biochemistry; 2012 Apr; 51(16):3394-403. PubMed ID: 22458807
[TBL] [Abstract][Full Text] [Related]
2. Phospholipase C-related but catalytically inactive protein, PRIP as a scaffolding protein for phospho-regulation.
Sugiyama G; Takeuchi H; Kanematsu T; Gao J; Matsuda M; Hirata M
Adv Biol Regul; 2013 Sep; 53(3):331-40. PubMed ID: 23911386
[TBL] [Abstract][Full Text] [Related]
3. Protein phosphatase regulation by PRIP, a PLC-related catalytically inactive protein--implications in the phospho-modulation of the GABAA receptor.
Yanagihori S; Terunuma M; Koyano K; Kanematsu T; Ho Ryu S; Hirata M
Adv Enzyme Regul; 2006; 46():203-22. PubMed ID: 16854455
[TBL] [Abstract][Full Text] [Related]
4. GBPI, a novel gastrointestinal- and brain-specific PP1-inhibitory protein, is activated by PKC and inactivated by PKA.
Liu QR; Zhang PW; Lin Z; Li QF; Woods AS; Troncoso J; Uhl GR
Biochem J; 2004 Jan; 377(Pt 1):171-81. PubMed ID: 12974676
[TBL] [Abstract][Full Text] [Related]
5. Phospholipase C-related catalytically inactive protein (PRIP) regulates lipolysis in adipose tissue by modulating the phosphorylation of hormone-sensitive lipase.
Okumura T; Harada K; Oue K; Zhang J; Asano S; Hayashiuchi M; Mizokami A; Tanaka H; Irifune M; Kamata N; Hirata M; Kanematsu T
PLoS One; 2014; 9(6):e100559. PubMed ID: 24945349
[TBL] [Abstract][Full Text] [Related]
6. Over activation of hippocampal serine/threonine protein phosphatases PP1 and PP2A is involved in lead-induced deficits in learning and memory in young rats.
Rahman A; Khan KM; Al-Khaledi G; Khan I; Al-Shemary T
Neurotoxicology; 2012 Jun; 33(3):370-83. PubMed ID: 22387731
[TBL] [Abstract][Full Text] [Related]
7. Phospholipase C-related but catalytically inactive protein (PRIP) modulates synaptosomal-associated protein 25 (SNAP-25) phosphorylation and exocytosis.
Gao J; Takeuchi H; Zhang Z; Fukuda M; Hirata M
J Biol Chem; 2012 Mar; 287(13):10565-10578. PubMed ID: 22311984
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship studies of fostriecin, cytostatin, and key analogs, with PP1, PP2A, PP5, and( beta12-beta13)-chimeras (PP1/PP2A and PP5/PP2A), provide further insight into the inhibitory actions of fostriecin family inhibitors.
Swingle MR; Amable L; Lawhorn BG; Buck SB; Burke CP; Ratti P; Fischer KL; Boger DL; Honkanen RE
J Pharmacol Exp Ther; 2009 Oct; 331(1):45-53. PubMed ID: 19592665
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of the CREB-specific coactivator TORC2 at Ser(307) regulates its intracellular localization in COS-7 cells and in the mouse liver.
Uebi T; Tamura M; Horike N; Hashimoto YK; Takemori H
Am J Physiol Endocrinol Metab; 2010 Sep; 299(3):E413-25. PubMed ID: 20551288
[TBL] [Abstract][Full Text] [Related]
10. Dissecting the sequence determinants for dephosphorylation by the catalytic subunits of phosphatases PP1 and PP2A.
Hoermann B; Kokot T; Helm D; Heinzlmeir S; Chojnacki JE; Schubert T; Ludwig C; Berteotti A; Kurzawa N; Kuster B; Savitski MM; Köhn M
Nat Commun; 2020 Jul; 11(1):3583. PubMed ID: 32681005
[TBL] [Abstract][Full Text] [Related]
11. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
[TBL] [Abstract][Full Text] [Related]
12. Glucose-induced posttranslational activation of protein phosphatases PP2A and PP1 in yeast.
Castermans D; Somers I; Kriel J; Louwet W; Wera S; Versele M; Janssens V; Thevelein JM
Cell Res; 2012 Jun; 22(6):1058-77. PubMed ID: 22290422
[TBL] [Abstract][Full Text] [Related]
13. Serine/threonine phosphatases: mechanism through structure.
Shi Y
Cell; 2009 Oct; 139(3):468-84. PubMed ID: 19879837
[TBL] [Abstract][Full Text] [Related]
14. Use of penetrating peptides interacting with PP1/PP2A proteins as a general approach for a drug phosphatase technology.
Guergnon J; Dessauge F; Dominguez V; Viallet J; Bonnefoy S; Yuste VJ; Mercereau-Puijalon O; Cayla X; Rebollo A; Susin SA; Bost PE; Garcia A
Mol Pharmacol; 2006 Apr; 69(4):1115-24. PubMed ID: 16387795
[TBL] [Abstract][Full Text] [Related]
15. A PP1-PP2A phosphatase relay controls mitotic progression.
Grallert A; Boke E; Hagting A; Hodgson B; Connolly Y; Griffiths JR; Smith DL; Pines J; Hagan IM
Nature; 2015 Jan; 517(7532):94-98. PubMed ID: 25487150
[TBL] [Abstract][Full Text] [Related]
16. Multiple structural elements define the specificity of recombinant human inhibitor-1 as a protein phosphatase-1 inhibitor.
Endo S; Zhou X; Connor J; Wang B; Shenolikar S
Biochemistry; 1996 Apr; 35(16):5220-8. PubMed ID: 8611507
[TBL] [Abstract][Full Text] [Related]
17. A direct interaction between the N terminus of adenylyl cyclase AC8 and the catalytic subunit of protein phosphatase 2A.
Crossthwaite AJ; Ciruela A; Rayner TF; Cooper DM
Mol Pharmacol; 2006 Feb; 69(2):608-17. PubMed ID: 16258073
[TBL] [Abstract][Full Text] [Related]
18. Stimulatory phosphorylation of cAMP-specific PDE4D5 by contractile agonists is mediated by PKC-dependent inactivation of protein phosphatase 2A.
Murthy KS; Sriwai W
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G327-35. PubMed ID: 18006600
[TBL] [Abstract][Full Text] [Related]
19. Binding of protein phosphatase 2A to the L-type calcium channel Cav1.2 next to Ser1928, its main PKA site, is critical for Ser1928 dephosphorylation.
Hall DD; Feekes JA; Arachchige Don AS; Shi M; Hamid J; Chen L; Strack S; Zamponi GW; Horne MC; Hell JW
Biochemistry; 2006 Mar; 45(10):3448-59. PubMed ID: 16519540
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of protein phosphatase-1 and -2A decreases the chemosensitivity of leukemic cells to chemotherapeutic drugs.
Dedinszki D; Kiss A; Márkász L; Márton A; Tóth E; Székely L; Erdődi F
Cell Signal; 2015 Feb; 27(2):363-72. PubMed ID: 25435424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
